Improved mapping of (pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents

被引:58
作者
Chen, YCI [1 ]
Mandeville, JB [1 ]
Nguyen, TV [1 ]
Talele, A [1 ]
Cavagna, F [1 ]
Jenkins, BG [1 ]
机构
[1] Massachusetts Gen Hosp, MGH NMR Ctr, Dept Radiobiochem, Charlestown, MA 02129 USA
关键词
CBV; CFT; BOLD; IRON; superparamagnetic; pharmacological MRI;
D O I
10.1002/jmri.1215
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The use of functional magnetic resonance imaging (fMRI) techniques for evaluation of pharmacologic stimuli has great potential for understanding neurotransmitter dynamics for a number of brain disorders, such as drug abuse, schizophrenia, epilepsy, or neurodegeneration. Unfortunately, blood oxygenation level-dependent (BOLD) imaging at common fields strengths, such as 1.5 or 3 T, has very low sensitivity and contrast-to-noise ratios (CNRs). We demonstrate here the utility of using an intravascular superparamagnetic iron oxide contrast agent with a long plasma half-life for evaluation of hemodynamic changes related to dopaminergic stimuli using amphetamine or the cocaine analog 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane (CFT). We refer to this technique as increased relaxation with iron oxide nanoparticles (IRON). Results obtained here show that even at field strengths as high as 4.7 T, one can obtain increases in CNR by factors of 2-3 over BOLD imaging that lead to greater than an order of magnitude increase in statistical power with greatly increased sensitivity to hemodynamic changes in brain regions difficult to observe using BOLD imaging. Furthermore, use of the intravascular contrast agent allows for a meaningful physiologic parameter to be measured (relative cerebral blood volume (rCBV)), compared to conventional BOLD imaging. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 45 条
[1]  
Barton JC, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P329
[2]   FUNCTIONAL MAPPING OF THE HUMAN VISUAL-CORTEX BY MAGNETIC-RESONANCE-IMAGING [J].
BELLIVEAU, JW ;
KENNEDY, DN ;
MCKINSTRY, RC ;
BUCHBINDER, BR ;
WEISSKOFF, RM ;
COHEN, MS ;
VEVEA, JM ;
BRADY, TJ ;
ROSEN, BR .
SCIENCE, 1991, 254 (5032) :716-719
[3]   Reduction of physiological fluctuations in fMRI using digital filters [J].
Biswal, B ;
DeYoe, EA ;
Hyde, JS .
MAGNETIC RESONANCE IN MEDICINE, 1996, 35 (01) :107-113
[4]   THE INTRAVASCULAR CONTRIBUTION TO FMRI SIGNAL CHANGE - MONTE-CARLO MODELING AND DIFFUSION-WEIGHTED STUDIES IN-VIVO [J].
BOXERMAN, JL ;
BANDETTINI, PA ;
KWONG, KK ;
BAKER, JR ;
DAVIS, TL ;
ROSEN, BR ;
WEISSKOFF, RM .
MAGNETIC RESONANCE IN MEDICINE, 1995, 34 (01) :4-10
[5]   Acute effects of cocaine on human brain activity and emotion [J].
Breiter, HC ;
Gollub, RL ;
Weisskoff, RM ;
Kennedy, DN ;
Makris, N ;
Berke, JD ;
Goodman, JM ;
Kantor, HL ;
Gastfriend, DR ;
Riorden, JP ;
Mathew, RT ;
Rosen, BR ;
Hyman, SE .
NEURON, 1997, 19 (03) :591-611
[6]   Noise suppression digital filter for functional magnetic resonance imaging based on image reference data [J].
Buonocore, MH ;
Maddock, RJ .
MAGNETIC RESONANCE IN MEDICINE, 1997, 38 (03) :456-469
[7]   INFLUENCE OF AMPHETAMINE SULFATE ON CEREBRAL BLOOD-FLOW AND METABOLISM [J].
CARLSSON, C ;
HAGERDAL, M ;
SIESJO, BK .
ACTA PHYSIOLOGICA SCANDINAVICA, 1975, 94 (01) :128-129
[8]   Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data [J].
Chen, YCI ;
Galpern, WR ;
Brownell, AL ;
Matthews, RT ;
Bogdanov, M ;
Isacson, O ;
Keltner, JR ;
Beal, MF ;
Rosen, BR ;
Jenkins, BG .
MAGNETIC RESONANCE IN MEDICINE, 1997, 38 (03) :389-398
[9]   Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment [J].
Chen, YI ;
Brownell, AL ;
Galpern, W ;
Isacson, O ;
Bogdanov, M ;
Beal, MF ;
Livni, E ;
Rosen, BR ;
Jenkins, BG .
NEUROREPORT, 1999, 10 (14) :2881-2886
[10]  
CHEN YI, 1999, P 7 ANN M ISMRM PHIL